Pharmaceutical Commerce - May/June 2011 - (Page 6)

Dispense as Written Pharmaceutical cargo theft plays big in mass media—but industry has already responded A n issue of Business Week magazine in late May had a feature story* on trucking cargo theft—particularly of pharmaceuticals; in March, Fortune magazine ran a similar feature.** Numerous data points, and a select number of incidents, highlight the problem, which is real. In mid-May, Pfizer experienced a theft when a trailer was stolen from a trucklot in Memphis; the value of the shipment is estimated at $66,000. But it’s also important to keep a sense of perspective about what problems are being managed, and which are out of control. The repercussions of the March 2010 warehouse burglary of Eli Lilly pharmaceuticals—valued at $76 million and arguably one of the most costly thefts of all time—still dominates many such discussions. But a Lilly source says that the company has far overreacted to the incident, driving up supply chain transportation costs to high, and unsustainable, levels. There’s a risk of an industry-wide overreaction. FreightWatch International, one of the organizations that collect incident data and do trends analysis, issued a five-year report in April showing that, while incidents involving pharma theft have quadrupled through 2010 (from a dozen in 2006 to nearly 50 last year), the 40-50 range has been a constant for the past three years. “Since 2008, the rate of growth has been almost flat, likely due to intense efforts by the Pharmaceutical industry to harden the supply chain,” summarizes the report’s author, senior director Dan Burges. No little credit should be given to Chuck Forsaith, director of corporate security at Purdue Pharma, who has bootstrapped a Pharma Cargo Security Coalition (pcscpharma.net) into being almost singlehandedly. FDA is now monitoring the drug-theft situation more closely, and is encouraging manufacturers to be forthright in sending notifications when thefts have occurred. These thefts, when the stolen products reach patients, become official “adverse events” that could harm the products’ viability. (The seriousness of drug theft, and the relatively minor penalties, have led to a new bill, S.1002, being introduced into Congress that essentially double the prison time for violators. HDMA’s president, John Gray, calls the action “an important step forward to further enhance the safety and security of our nation’s healthcare supply chain.”) The risks of pharma theft are not to be minimized: besides the economic loss itself, products trickle back into legitimate distribution, and into retail or hospital pharmacies, there to put patients’ lives at risk. The Fortune and BW articles document stolen products later showing up in retail pharmacy shelves; other incidents involving glucose test strips or other products have been documented. Manufacturers’ usual recourse, when a shipment has been stolen, is to recall the entire lot (and hope that the recall actually works; they are seldom 100% effective). There are two takeaways from the current situation: pharma security and supply chain managers need to be listened to when they identify security gaps in product distribution; ditto for the transportation managers at distributors, and the receiving personnel at retail and hospital end points. Secondly, while the industry overall appears to be dealing with the problem effectively, it’s never going to go away entirely. Stolen or diverted product will continue to show up, whether or not it travels through the “normal distribution channel” that some authorities claim protects the American consumer. All this is occurring at a time when thousands of “prescriptions” (which frequently do not involve a licensed medical professional operating according to industry standards) are being mailed from Internet pharmacies to woefully naïve individual buyers. Product serialization, effective track-and-trace systems, and usable authentication methods need to be part of the picture. *http://www.businessweek.com/magazine/content/11_23/b4231072707549.htm **http://features.blogs.fortune.cnn.com/2011/03/31/drug-theft-goes-big/ . Nicholas Basta Editor in Chief Sign up for the FREE eNewsletter Delivered biweekly to your emailbox. Go to PharmaceuticalCommerce.com, click on “newsletter” 6 May | June 2011 www.PharmaceuticalCommerce.com http://www.pcscpharma.net http://www.pcscpharma.net http://www.businessweek.com/magazine/content/11_23/b4231072707549.htm http://features.blogs.fortune.cnn.com/2011/03/31/drug-theft-goes-big/ http://www.PharmaceuticalCommerce.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - May/June 2011

Pharmaceutical Commerce - May/June 2011
Table of Contents
Editorial
Op-Ed
Top News
Business / Finance
Brand Communications
Supply Chain / Logistics
Information Technology
Legal/ Regulatory
Executive Development
Meetings and Editorial Index

Pharmaceutical Commerce - May/June 2011

https://www.nxtbook.com/nxtbooks/pharmcomm/202006
https://www.nxtbook.com/nxtbooks/pharmcomm/202003
https://www.nxtbook.com/nxtbooks/pharmcomm/201911
https://www.nxtbook.com/nxtbooks/pharmcomm/201909
https://www.nxtbook.com/nxtbooks/pharmcomm/201906
https://www.nxtbook.com/nxtbooks/pharmcomm/201903
https://www.nxtbook.com/nxtbooks/pharmcomm/201811
https://www.nxtbook.com/nxtbooks/pharmcomm/201809
https://www.nxtbook.com/nxtbooks/pharmcomm/201806
https://www.nxtbook.com/nxtbooks/pharmcomm/20180304
https://www.nxtbook.com/nxtbooks/pharmcomm/20171112
https://www.nxtbook.com/nxtbooks/pharmcomm/20170910
https://www.nxtbook.com/nxtbooks/pharmcomm/20170708
https://www.nxtbook.com/nxtbooks/pharmcomm/20170506
https://www.nxtbook.com/nxtbooks/pharmcomm/20170304
https://www.nxtbook.com/nxtbooks/pharmcomm/20170102
https://www.nxtbook.com/nxtbooks/pharmcomm/20161112
https://www.nxtbook.com/nxtbooks/pharmcomm/20160910
https://www.nxtbook.com/nxtbooks/pharmcomm/20160708
https://www.nxtbook.com/nxtbooks/pharmcomm/20160506
https://www.nxtbook.com/nxtbooks/pharmcomm/20160304
https://www.nxtbook.com/nxtbooks/pharmcomm/20160102
https://www.nxtbook.com/nxtbooks/pharmcomm/20151112
https://www.nxtbook.com/nxtbooks/pharmcomm/20150910
https://www.nxtbook.com/nxtbooks/pharmcomm/20150708
https://www.nxtbook.com/nxtbooks/pharmcomm/20150506
https://www.nxtbook.com/nxtbooks/pharmcomm/20150304
https://www.nxtbook.com/nxtbooks/pharmcomm/20150102
https://www.nxtbook.com/nxtbooks/pharmcomm/20141112
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
https://www.nxtbook.com/nxtbooks/pharmcomm/20140910
https://www.nxtbook.com/nxtbooks/pharmcomm/20140708
https://www.nxtbook.com/nxtbooks/pharmcomm/20140506
https://www.nxtbook.com/nxtbooks/pharmcomm/20140304
https://www.nxtbook.com/nxtbooks/pharmcomm/20140102
https://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
https://www.nxtbook.com/nxtbooks/pharmcomm/20131112
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
https://www.nxtbook.com/nxtbooks/pharmcomm/20130910
https://www.nxtbook.com/nxtbooks/pharmcomm/20130708
https://www.nxtbook.com/nxtbooks/pharmcomm/20130506
https://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
https://www.nxtbook.com/nxtbooks/pharmcomm/20130304
https://www.nxtbook.com/nxtbooks/pharmcomm/20130102
https://www.nxtbook.com/nxtbooks/pharmcomm/20121112
https://www.nxtbook.com/nxtbooks/pharmcomm/20120910
https://www.nxtbook.com/nxtbooks/pharmcomm/20120708
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506
https://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
https://www.nxtbook.com/nxtbooks/pharmcomm/20120304
https://www.nxtbook.com/nxtbooks/pharmcomm/20120102
https://www.nxtbook.com/nxtbooks/pharmcomm/20111112
https://www.nxtbook.com/nxtbooks/pharmcomm/20110910
https://www.nxtbook.com/nxtbooks/pharmcomm/20110708
https://www.nxtbook.com/nxtbooks/pharmcomm/20110506
https://www.nxtbook.com/nxtbooks/pharmcomm/20110304
https://www.nxtbook.com/nxtbooks/pharmcomm/20110102
https://www.nxtbook.com/nxtbooks/pharmcomm/20101112
https://www.nxtbook.com/nxtbooks/pharmcomm/20100910
https://www.nxtbook.com/nxtbooks/pharmcomm/20100708
https://www.nxtbook.com/nxtbooks/pharmcomm/20100506
https://www.nxtbook.com/nxtbooks/pharmcomm/201004
https://www.nxtbook.com/nxtbooks/pharmcomm/201003
https://www.nxtbook.com/nxtbooks/pharmcomm/20100102
https://www.nxtbook.com/nxtbooks/pharmcomm/20091112
https://www.nxtbookmedia.com